FRANKFURT (Dow Jones)--Evotec AG (EVT.XE) and German pharmaceutical and chemical company Merck KGaA will collaborate on an undisclosed neurological disease, Evotec said in a statement Tuesday.

MAIN FACTS:

-The companies will develop pre-clinical candidates for the neurological disease.

-The project is partially funded by the Federal Ministry of Education and Research.

-Frankfurt Bureau, Dow Jones Newswires; 49-69-29725-500